-
Type 1 Lysophosphatidic Acid Receptor (LPA1) Inhibitor Market 2020 Global Research Report | Ube Industries, Bristol-Myers Squibb, Roche, Lpath
09 Oct 2020 08:10 GMT
… Industries, Bristol-Myers Squibb, Roche, Lpath and others.
Lysophosphatidic acids (LPA … the detailed chemical nature and pharmacological profile of the small-molecules … on the preparation of key pharmaceuticals. This summary will facilitate future …
-
Diabetic Retinopathy Market Trends and Forecast to 2023: Bayer, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals.
27 Feb 2019 21:12 GMT
… , iCo Therapeutics, Isis Pharmaceuticals, Kowa Group, Lpath, Numoda Capital, Ohr Pharmaceutical, OPKO Health … , Parexel International, Promedior, pSivida, Quark Pharmaceuticals …
-
Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028 - Visiongain Report
24 Jul 2018 14:34 GMT
… Ophthalmics
Kyorin Pharmaceutical
Kyowa Hakko Kirin
LEO Pharma
Lpath
MacuCLEAR
MacuSIGHT, … Inc.
MAP Pharmaceuticals (acquired by … of Boehringer Ingelheim)
NovaBay Pharmaceuticals
Novagali Pharma (acquired by Santen)
…
-
Spinal cord injury Pharmaceutical and Healthcare Pipeline Review H2
06 Jan 2017 08:24 GMT
… breathing after injury.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide … . The guide covers the descriptive pharmacological action of the therapeutics, its …
Kadimastem Ltd 31
Kringle Pharma Inc 32
Lpath Inc 33
MandalMed Inc …
-
Tuesday’s Biggest Biotech and Pharma Moves
03 Jan 2017 16:15 GMT
… the previously public company Lpath. The deal originally was … terms of the agreement, Lpath issued new shares of its … combined company and the Lpath security holders are expected … to $20.00.
Tracon Pharmaceuticals
Tracon Pharmaceuticals Inc. (NASDAQ: TCON) …